Compare FMC Corp (FMC) vs BlackRock TCP Capital Corp (TCPC) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

BlackRock TCP Capital Corp. (TCPC) trades at $3.32, up 5.06% on the day, against a backdrop of mixed technical and fundamental signals. The stock is technically bearish with key moving averages signaling caution, while fundamental metrics show a challenging picture with negative revenue and net income, though a low P/B ratio of 0.49 suggests potential undervaluation. Recent news includes a Zacks upgrade to 'Buy' and an upcoming Q2 2026 earnings report on August 6, 2026.

The outlook for TCPC is clouded by persistent negative profitability and a shareholder lawsuit investigation, presenting significant risk. However, a discounted book value, a stable dividend, and a recent analyst upgrade offer a potential value opportunity for income-focused investors willing to tolerate high volatility and fundamental uncertainty.